Intervention Protocol

Imatinib for treating patients with chronic myelogeneous leukemia

  1. Vinicio Navas1,*,
  2. Daniel Simancas1,
  3. Luis Ernesto González1,
  4. Ricardo Hidalgo1,
  5. Andrés Felipe Cardona2,
  6. Arturo J Martí-Carvajal3

Editorial Group: Cochrane Haematological Malignancies Group

Published Online: 20 JAN 2010

DOI: 10.1002/14651858.CD008259


How to Cite

Navas V, Simancas D, González LE, Hidalgo R, Cardona AF, Martí-Carvajal AJ. Imatinib for treating patients with chronic myelogeneous leukemia (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD008259. DOI: 10.1002/14651858.CD008259.

Author Information

  1. 1

    Universidad Tecnológica Equinoccial, Facultad de Ciencias de la Salud Eugenio Espejo, Quito, Ecuador

  2. 2

    Catalan Institute of Oncology, Hospital Germans Trias I Pujol, Department of Medical Oncology, Badalona, Barcelona, Spain

  3. 3

    Iberoamerican Cochrane Network, Valencia, Edo. Carabobo, Venezuela

*Vinicio Navas, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad Tecnológica Equinoccial, Bourgeois N34-102 y Rumipamba, Quito, 17 01 2764, Ecuador. vnavas@ute.edu.ec.

Publication History

  1. Publication Status: New
  2. Published Online: 20 JAN 2010

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.